Neurocrine Biosciences (NBIX) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $161.63 +0.01%
Revenue Growth %: +26.4%
Financial Fact:
Total revenues: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +26.4%
Financial Fact:
Total revenues: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
- Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
